Cours Innovus Pharmaceuticals Inc OTC Bulletin Board
Actions
US45778V1061
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+56,89% | 809 Md | |
+39,52% | 624 Md | |
-6,55% | 351 Md | |
+7,92% | 289 Md | |
+13,74% | 240 Md | |
+13,83% | 220 Md | |
-0,49% | 219 Md | |
+7,94% | 166 Md | |
-2,57% | 157 Md |